The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease

(2014) Shigeru Iwata et al.   Modern Rheumatology

Clinical Course of Intestinal Behcet’s Disease During the First Five Years

(2012) Yoon Suk Jung et al.   DIGESTIVE DISEASES AND SCIENCES

A Case of Intestinal Beh^|^ccedil;et's Disease Treated with Infliximab Monotherapy Who Successfully Maintained Clinical Remission and Complete Mucosal Healing for Six Years

(2012) Yuriko Maruyama et al.   INTERNAL MEDICINE

Infliximab for the Treatment of Refractory Adamantiades-Behçet Disease with Articular, Intestinal, Cerebral and Ocular Involvement

(2010) Davide Donghi et al.   DERMATOLOGY

Behçetʼs disease

(2009) Ilan Krause et al.   CURRENT OPINION IN RHEUMATOLOGY

Infliximab as an Alternative Treatment for Behçet Disease When Other Therapies Fail

(2009) Meltem Ugras et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Efficacy of infliximab for induction and maintenance of remission in intestinal Behçetʼs disease

(2008) Makoto Naganuma et al.   INFLAMMATORY BOWEL DISEASES